Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy with weekly gemcitabine for bladder cancer
ISRCTN64153246Phase 2Completed
- Sponsor
- The Christie
- Start
- Jul 2003
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine in bladder cancer, sponsored by The Christie. Primary endpoint: Tumor response. Started Jul 2003; status: completed.
02
Drugs
gemcitabine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on ISRCTN64153246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN64153246.